Australia has provided more than 2.5 million COVID-19 vaccine doses to Pacific Island countries, and 15 million doses to Southeast Asia. Australia has committed to providing 60 million doses in total by the end of 2022, the majority of which will be AstraZeneca vaccines that are produced in Australia.
Australia has also partnered with the World Bank to study vaccine hesitancy in the Philippines. According to the study, the main reasons for hesitancy appear to be insufficient information about vaccines available to individuals, mistrust of vaccine information or its source, and incorrect assessment of the relative benefits of the vaccine and its risks.
The research suggested that respondent mistrust could be tackled by asking individuals to consider who should endorse and exert a positive influence on the vaccination campaign. Other proposals included providing simplified information, having individuals consider what activities they would look forward to in 'normal' times, and asking them to identify who they most think about and want to protect.